Axsome Therapeutics Historical PE Ratio image   This AXSM PE ratio history page last updated 4/11/2024
Axsome Therapeutics Historical PE Ratio Chart
PeriodPriceAdj. EPSAnnualizedPE
Q4 2023
2/20/2024
81.14-0.73-2.92NA
Q3 2023
11/6/2023
62.42-1.32-5.28NA
Q2 2023
8/7/2023
71.09-1.54-6.16NA
Q1 2023
5/8/2023
77.73-0.26-1.04NA
Q4 2022
2/27/2023
64.08-1.41-5.64NA
Q3 2022
11/7/2022
56.82-1.07-4.28NA
Q2 2022
8/9/2022
44.76-1.06-4.24NA
Q1 2022
5/2/2022
34.04-1.03-4.12NA
Q4 2021
3/1/2022
30.98-0.90-3.60NA
Q3 2021
11/8/2021
43.36-0.93-3.72NA
Q2 2021
8/9/2021
27.37-0.86-3.44NA
Q1 2021
5/10/2021
54.39-0.78-3.12NA
Q4 2020
3/1/2021
69.20-0.78-3.12NA
Q3 2020
11/5/2020
69.51-0.61-2.44NA
Q2 2020
8/10/2020
81.79-0.49-1.96NA
Q1 2020
5/8/2020
87.97-0.88-3.52NA
Q4 2019
3/12/2020
64.78-0.71-2.84NA
Q3 2019
11/7/2019
23.27-0.56-2.24NA
Q2 2019
8/8/2019
25.50-0.41-1.64NA
Q1 2019
5/9/2019
19.81-0.32-1.28NA
Q4 2018
3/14/2019
10.71-0.32-1.28NA
Q3 2018
11/9/2018
3.87-0.31-1.24NA
Q2 2018
8/8/2018
2.55-0.32-1.28NA
Q1 2018
5/8/2018
3.30-0.19-0.76NA
Q4 2017
3/7/2018
2.80-0.31-1.24NA
Q3 2017
11/8/2017
4.60-0.27-1.08NA
Q2 2017
8/9/2017
5.85-0.30-1.20NA
Q1 2017
5/9/2017
4.20-0.41-1.64NA
Q4 2016
3/7/2017
4.45-0.38-1.52NA
Q3 2016
11/14/2016
7.50-0.38-1.52NA
Q2 2016
8/9/2016
7.61-0.36-1.44NA
Q1 2016
5/11/2016
11.18-0.31-1.24NA
Q4 2015
3/24/2016
8.50-0.12-0.48NA
Axsome Therapeutics PE History Chart
PeriodPriceAdj. EPSTTMPE
Q4 2023
2/20/2024
81.14-0.73-3.85NA
Q3 2023
11/6/2023
62.42-1.32-4.53NA
Q2 2023
8/7/2023
71.09-1.54-4.28NA
Q1 2023
5/8/2023
77.73-0.26-3.80NA
Q4 2022
2/27/2023
64.08-1.41-4.57NA
Q3 2022
11/7/2022
56.82-1.07-4.06NA
Q2 2022
8/9/2022
44.76-1.06-3.92NA
Q1 2022
5/2/2022
34.04-1.03-3.72NA
Q4 2021
3/1/2022
30.98-0.90-3.47NA
Q3 2021
11/8/2021
43.36-0.93-3.35NA
Q2 2021
8/9/2021
27.37-0.86-3.03NA
Q1 2021
5/10/2021
54.39-0.78-2.66NA
Q4 2020
3/1/2021
69.20-0.78-2.76NA
Q3 2020
11/5/2020
69.51-0.61-2.69NA
Q2 2020
8/10/2020
81.79-0.49-2.64NA
Q1 2020
5/8/2020
87.97-0.88-2.56NA
Q4 2019
3/12/2020
64.78-0.71-2.00NA
Q3 2019
11/7/2019
23.27-0.56-1.61NA
Q2 2019
8/8/2019
25.50-0.41-1.36NA
Q1 2019
5/9/2019
19.81-0.32-1.27NA
Q4 2018
3/14/2019
10.71-0.32-1.14NA
Q3 2018
11/9/2018
3.87-0.31-1.13NA
Q2 2018
8/8/2018
2.55-0.32-1.09NA
Q1 2018
5/8/2018
3.30-0.19-1.07NA
Q4 2017
3/7/2018
2.80-0.31-1.29NA
Q3 2017
11/8/2017
4.60-0.27-1.36NA
Q2 2017
8/9/2017
5.85-0.30-1.47NA
Q1 2017
5/9/2017
4.20-0.41-1.53NA
Q4 2016
3/7/2017
4.45-0.38-1.43NA
Q3 2016
11/14/2016
7.50-0.38-1.17NA
Q2 2016
8/9/2016
7.61-0.36NANA
Q1 2016
5/11/2016
11.18-0.31NANA
Q4 2015
3/24/2016
8.50-0.12NANA
Quotes delayed 20 minutes

Email EnvelopeFree AXSM Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Axsome Therapeutics (AXSM) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

AYTU PE Ratio History
AZRX PE Ratio History
AZYO PE Ratio History
BACK PE Ratio History
BAX PE Ratio History
BBI PE Ratio History
BBIO PE Ratio History
BBLG PE Ratio History
BCAB PE Ratio History
BCDA PE Ratio History
How should the AXSM historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Axsome Therapeutics. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this AXSM Historical PE Ratio page.

What is the average historical PE for AXSM based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The AXSM historical PE ratio using the annualized quarterly earnings method works out to NA.

What is the average historical PE for AXSM based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The AXSM historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the Axsome Therapeutics Historical PE Ratio information for Axsome Therapeutics' stock. The average AXSM historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average AXSM historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this AXSM historical PE result, against the recent PE: when this page was posted on 4/10/2024, the most recent closing price for AXSM had been 70.97, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on AXSM or any other given stock, valuation analysis for AXSM can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Axsome Therapeutics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for AXSM. Thanks for visiting, and the next time you need to research AXSM Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: CLBK Stock Predictions, Funds Holding AGL, MTW shares outstanding history.

 

Axsome Therapeutics Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.